Mamounas EP, Untch M, Mano MS, Huang CS, et al. Adjuvant T-DM1 versus Trastuzumab in Patients with Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer: Subgroup Analyses from KATHERINE. Ann Oncol 2021 Apr 28. pii: S0923-7534(21)01168.
PMID: 33932503